RxDoctor Payments Data

Richard Vonder Brink, MD

Family Medicine · Cincinnati, OHNPI 1841282761

Payments from drug & device makers

$7,908in general payments, 2019–2025

Across 516 payments — averaging $15.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$992
  • Pfizer$917
  • Lilly USA, LLC$439
  • AstraZeneca$405
  • Merck$381
  • plus $4K from 44 others

What the payments were for

  • Food & beverage$7,908100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,908 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$96,911
Medicare patients
223
Services billed
996

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin62$79,051
OzempicSemaglutide60$68,007
EliquisApixaban71$66,309
TrulicityDulaglutide43$54,206
MounjaroTirzepatide40$46,426
FarxigaDapagliflozin Propanediol17$25,245
XareltoRivaroxaban16$23,258
MyrbetriqMirabegron16$17,229
JanuviaSitagliptin Phosphate14$16,778
LinzessLinaclotide12$12,418
Tresiba Flextouch U-100Insulin Degludec12$10,855
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,617
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$3,441
Atorvastatin Calcium386$2,627
Celecoxib80$2,367

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$439$100,63183 claims
Boehringer IngelheimJardiance$249$79,05162 claims
Novo NordiskOzempic$992$68,00760 claims
PfizerEliquis, Paxlovid$917$67,73882 claims
AstraZenecaFarxiga, Breztri Aerosphere$405$32,86129 claims
Johnson & JohnsonXarelto$176$23,25816 claims
Astellas Pharma US IncMyrbetriq$237$17,22916 claims
MerckJanuvia$381$16,77814 claims
AbbVieLinzess$1,121$12,41812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →